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Abstract
Introduction: Malignant pericardial effusion is the 
accumulation of liquid in the pericardial space secondary to 
advanced stage neoplasia, becoming in an indicator of bad 
prognosis. Malignant tumors that are most often related to 
this entity are the ones from pulmonary, mammary, and 
hematolymphoid origin. Clinically, it may present imminent 
signs of cardiac tamponade and hemodynamic instability, so 
that it merits an early diagnosis and management with 
emerging decompression maneuvers. Objective: This 
article presents a malignant pericardial effusion case, since 
this clinical condition implies a diagnostic challenge. Case 
presentation and Conclusions: A case of a 63 year old 
male patient is presented. He has one month of clinical 
evolution characterized by cervical adenopathies, also in the 
past fifteen days has been presenting precocious satiety, 
nocturnal sweating, sensation of distended abdomen, and 
functional class deterioration to having dyspnea during small 
physical efforts. This was the reason why he went to the 
emergency room. During the medical observation, the 
patient quickly deteriorates to hemodynamic instability, 
refractory to treatment. Some imaging studies were 
performed, which show severe pericardial effusion so a 
decompressive pericardiocentesis and a multidisciplinary 
integral management were performed. [Chilatra-Fonseca 
JM, Morales-Camacho WJ, Plata-Ortiz JE, Gómez-Mancilla 
YP, Villabona-Rosales SA. Malignant Pericardial Effusion 
Secondary to Lung Adenocarcinoma: Case Report. 
MedUNAB 2017; 20(1): 63-69].
Keywords: Cardiac Tamponade; Pericardial Effusion; Lung 
Neoplasms; Neoplasm Invasiveness; Pericardiocentesis.
*     Médico General, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. Grupo de Investigaciones Clínicas – Semillero de urgencias y trauma, 
Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. 
**  Médica Interna, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. Grupo de Investigaciones Clínicas – Semillero de urgencias y trauma, 
Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. 
*** Médico, Especialista en Urgenciología. Fundación Oftalmológica de Santander – FOSCAL. Docente asociado, Universidad Autónoma de Bucaramanga, 
Bucaramanga, Colombia. Grupo de Investigaciones Clínicas – Semillero de urgencias y trauma, Universidad Autónoma de Bucaramanga, Bucaramanga, 
Colombia.  
Correspondencia: José Mauricio Chilatra Fonseca. Universidad Autónoma de Bucaramanga, Calle 157 No. 19-55 Cañaveral Parque Floridablanca, Santander, 
Colombia. Telephone: +57 317 625 9367. Email: jchilatra@unab.edu.co . 
Artículo recibido: 19 de octubre de 2015                         Aceptado: : 2 de febrero de 2017
Malignant Pericardial Effusion Secondary to Lung 
Adenocarcinoma: Case Report 
Derrame pericárdico maligno secundario a adenocarcinoma de 
pulmón: Reporte de caso
Derrame pericárdico maligno secundário ao adenocarcinoma 
pulmonar: relato de caso
José Mauricio Chilatra-Fonseca, MD. *
William Javier Morales-Camacho, MD. *
Jessica Estefanía Plata-Ortiz, MD. *
Yisela Patricia Gómez-Mancilla, MD. **









Introducción: El derrame pericárdico maligno es la 
acumulación de líquido en el espacio pericárdico secundario 
a neoplasias en estadios avanzados, siendo así, un indicador 
de mal pronóstico. Los tumores malignos que con mayor 
frecuencia se relacionan con esta entidad son los de origen 
pulmonar, mamario y hematolinfoides. Clínicamente puede 
cursar con signos inminentes de taponamiento cardiaco e 
inestabilidad hemodinámica, por lo que amerita un 
diagnóstico temprano y manejo urgente con maniobras de 
descompresión.  Objetivo: Este articulo busca presentar un 
caso de derrame pericárdico maligno, debido a que esta 
condición clínica implica un reto diagnóstico. Presentación 
del caso y conclusiones: Presentamos el caso de un 
paciente masculino de 63 años de edad, con cuadro clínico 
de 1 mes de evolución, caracterizado por presencia de 
adenopatías cervicales, quien en los últimos 15 días presenta 
saciedad precoz, sudoración nocturna, sensación de 
distensión abdominal y deterioro de la clase funcional hasta 
disnea de pequeños esfuerzos, motivo por el cual consulta al 
servicio de urgencias. Durante la observación médica 
rápidamente progresa a inestabilidad hemodinámica, 
refractaria a manejo; se realizan estudios imagenológicos, en 
donde se evidencia derrame pericárdico severo, por lo que se 
procede a realizar pericardiocentesis descompresiva 
emergente y manejo integral multidisciplinario. [Chilatra-
Fonseca JM, Morales-Camacho WJ, Plata-Ortiz JE, Gómez-
Mancilla YP, Villabona-Rosales SA.  Derrame pericárdico 
maligno secundario a adenocarcinoma de pulmón: Reporte 
de caso. MedUNAB 2017; 20(1): 63-69].
Palabras clave: Taponamiento Cardíaco; Derrame 
Pericárdico; Neoplasias Pulmonares; Invasividad Neoplásica; 
Pericardiocentesis.
Resumo
Introdução: O derrame pericárdico maligno é o acúmulo de 
líquido no espaço pericárdico secundário a neoplasias em 
estádios avançados, sendo, portanto, um indicador de mau 
prognóstico. Os tumores malignos, frequentemente 
associados a esta categoría, são aqueles de origem 
pulmonar, mamária e hematolinfóides. Clinicamente, podem 
apresentar sinais iminentes de tamponamento cardíaco e 
instabilidade hemodinâmica, o que justifica um diagnóstico 
precoce e  t ra tamento  urgente  com manejo  de 
descompressão. Objetivo: Este artigo tem como objetivo 
apresentar um caso de derrame pericárdico maligno, pois 
esta condição clínica implica um desafio diagnóstico. 
Apresentação e conclusões do caso: apresentamos o 
caso de um paciente do sexo masculino de 63 anos, com o 
quadro clínico de 1 mês de evolução, caracterizado pela 
presença de linfadenopatia cervical, que nos últimos 15 dias 
apresenta saciedade precoce, sudação noturna, distensão 
abdominal e deterioração da classe funcional até a dispnéia 
de pequenos esforços, motivo pelo qual consulta o serviço 
de emergência. Durante a observação médica, ele progride 
rapidamente para a instabilidade hemodinâmica, refratária 
ao manejo; Estudos de imagem são realizados, nos quais o 
derrame pericárdico grave é evidente, por isso é necessário 
realizar pericardiocentese descompressiva emergente e 
gerenciamento integral multidisciplinar. [Chilatra-Fonseca 
JM, Morales-Camacho WJ, Plata-Ortiz JE, Gómez-Mancilla 
YP, Villabona-Rosales SA. Derrame pericárdico maligno 
secundário ao adenocarcinoma pulmonar: relato de caso. 
MedUNAB 2017; 20 (1): 63-69].
Palavras chaves: Tamponamento Cardíaco; Derrame 
Pericárdico; Neoplasias Pulmonares; Invasividade Neoplásica; 
Pericardiocentese.
Introduction
Pericardial effusion (PE) is defined as the accumulation of 
fluid in the pericardial space secondary to an injury or 
inflammation. Its etiology has been associated with various 
conditions or events, among the most common are the 
infectious, traumatic, metabolic, autoimmune, neoplastic 
and induced by radiotherapy and chemotherapy origin (1). 
Also, depending on the etiology, the type of pericardial fluid 
may be transudate or exudate (2).
Malignant pericardial effusion (MPE) has a great impact on 
morbidity and mortality of patients, with a reported 
prevalence up to 21% associated with an advanced state of 
neoplastic diseases (3, 4). The primary malignancies of 
lung, breast and hematolymphoid, are the ones that most 
often associate with this pathology (5). In autopsies of 
patients with different types of cancer have been 
demonstrated a compromise of up to 20% of the pericardium 
(6). It should be noted that the MPE is an indicator of poor 
prognosis; it can show some signs of impending cardiac 
tamponade and is clinically characterized by a 
hemodynamic instability secondary to increased pressure 
due to a pericardial fluid accumulation that requires 
emergent decompression maneuvers (7, 8). 
A chest x-ray is a diagnostic help which can show, in some 
cases, an enlarged and rounded cardiac silhouette; however, 
this finding can be limited by the presence of other 
thoracoabdominal entities. It presents a low sensibility and 
specificity. Transthoracic echocardiography is another 
diagnostic tool, which is the best diagnostic tool to evaluate 
a pericardial compromise, and followed by a computed 
tomography (CT) and a magnetic resonance imaging 
(MRI). These tools are useful in evaluating the presence of 
intrapericardial masses and pericardial effusion when 
ultrasonography is inconclusive (9, 10). Another diagnostic 
tool is the biochemical and histopathological analysis of the 
pericardial effusion; it should be noted that there is the 
likelihood of false negatives due to a low concentration of 
tumor cells in the sample (11).
A pericardial effusion treatment aims to suppress its 
symptoms, restore hemodynamic stability and prevent 
 recurrence (6).There has been evidence of a recurrence rate 
of 40% of MPE in patients who do not receive additional 
treatment such as continuous drainage catheter, performing 
a pericardial window or sclerosing therapy (12). The 
objective of this article is to present a malignant pericardial 
effusion case, since this clinical condition implies a 
diagnostic challenge. 
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A 63-year old male patient from Bucaramanga, Colombia; 
with one month of clinical evolution characterized by the 
presence of cervical lymphadenopathy initially painful, with 
progressive enlargement, associated with fatigue and 
adynamia. Over the past 15 days, he has been presenting 
early satiety, night sweats, feeling of abdominal distension 
and impaired functional class to dyspnea when doing small 
efforts; this was the reason why he consulted the emergency 
department at a tertiary institution in the metropolitan area of 
Bucaramanga (Colombia). Systems review referred 
oliguria, dark urine, and weight loss of approximately 3 
kilograms in the last month. Personal history of importance 
showed arterial hypertension in treatment and exposure to 
organic material (straw) for 10 years. 
The physical exam during his admission revealed that the 
patient is alert, oriented, and collaborative with vital signs 
of AP: 129/80 mmHg and CF: 93 per minute, oxygen 
saturation of 93%, and a temperature of 36.5C. His oral 
mucosa  i s  d r i ed ,  r igh t  submaxi l l a ry  ce rv ica l 
lymphadenopathies of approximately 3X4 cm, jugular 
ingurgitation grade I, cardiac rhythm veiled with a murmur, 
pulmonary sounds diminished with expiratory wheezing 
and moist rales in the left lung base. Abdomen distended 
with tympanic percussion, without masses or adenopathies. 
Left axillary region with an adenomegalia of 3X2 cm, not 
painful, of rubbery consistency, mobile; and a palpable 
mass in the right scapular region of approximately 6X3 cm, 
rubbery consistency, and painful during palpation. D uring 
the initial assessment, laboratories tests were requested and 
the results showed eight times, from its normal value, 
elevated transaminases, hyperbilirubinemia at the expense 
of direct, hyperlactatemia and impaired renal function; his 
chest radiography has an increased heart silhouette; also, 
retrocardial opacity was observed without the air 
bronchogram (Figure 1). 
Moreover, hypotension, tachypnea, hypoventilation 
predominantly of left basal hemi thorax was documented 
during his clinical stay; the volume resuscitation maneuvers 
were initiated with a partial response; therefore, an 
ultrasound was performed with pericardial window, in 
which the presence of pericardial effusion was observed 
(approximately 400cc). A simple and contrasted 
thoracoabdominal CT was performed; it was identified an 
endobronchial lesion affecting one of the left lower lobe 
bronchus, apparently in the apical segment, mediastina 
lymphadenopathy and severe pericardial effusion (Figure 
2); also, an osteolytic lesion in the right scapula suggestive 
of metastases (Figure 3). At the abdominal level, bilateral 
Figure 2. CHEST CT. (A) Endobronchial lesion involving one of the left lower lobe bronchus. 
(B) Important pericardial effusion, (C) Mediastinal adenopathy and left axillary adenopathy. 
Figure 1. CHEST X-RAY. Widened mediastinum and 
retrocardiac opacity showing no air bronchogram. 
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adrenal masses of probable metastatic origin and free liquid 
in abdominal cavity of moderate quantity were observed. 
The patient rapidly progresses to hemodynamic instability, 
persistent hypotension, tachycardia, veiled heart sounds, 
intolerance decubitus, and jugular grade II ingurgitation; in 
ECG monitoring, low voltage in all leads was observed 
with signs of early repolarization, reason why cardiac 
tamponade was suspected. 
A general surgery was performed. It was executed under 
ultrasound guidance and confirmation of a decompressive 
pericardiocentesis and pericardiotomy with catheter 
placement for drainage, draining a total of 300 mL of 
serohematic fluid, achieving hemodynamic compensation 
and electrocardiogram voltage increase, sinus rhythm, and 
wide QRS in cardiovisoscopy. The fluid was sent for 
biochemical and histopathology study. The cytology study 
showed positive for malignancy, suggestive of 
adenocarcinoma.
This was a study of the pericardial fluid cell block with 
adenocarcinoma compromise of micropapillary pattern. 
This immunohistochemistry was consistent with pulmonary 
origin. The patient was moved to intensive care unit, with 
evolution within management goals, hemodynamically 
stable without ventilator requirements or vasopressor 
support. Therefore, patient was transferred to continue his 
hospitalization out of the ICU. Once the patient was stable, a 
CT-guided lung biopsy performed by interventional 
radiology was requested; however, the patient and his 
family did not give their consent for the procedure, and 
requested voluntary discharge seeing that the patient has a 
stable condition.
On the second day after hospital discharge, the patient 
entered to the emergency department after approximately 48 
hours. His clinical condition was characterized by pain in 
the right scapular region of 9/10 intensity according to the 
analog scale of pain radiating to the right arm, without 
response to analgesic management. He also refers that 12 
hours ago, he started with a progressive dyspnea when doing 
small efforts. Upon physical examination the patient was 
alert, conscious, irritable, oriented, without oxygen support, 
with decreased peripheral pulses, blood pressure readings 
with a tendency to hypotension, decreased breath sounds in 
left part of the chest, veiled heart sounds without murmurs, 
and the rest of the examination is unchanged. Therefore, 
extension tests and a transthoracic echocardiogram, which 
showed ejection fraction between 55 and 60%, pericardial 
thickening and constriction and mild pericardial effusion 
were ordered, reason why cardiology ruled out the suspicion 
of cardiac tamponade. Close clinical surveillance was 
continued, with a favorable evolution. The family and 
patient agreed to perform the biopsy and the procedure was 
performed without any complications, pathology reports 
confirmed adenocarcinoma of micropapillary pattern, so an 
integrated management was continued.
Discussion
MPE is an indicator of poor prognosis and clinically, patients 
may present signs of impending cardiac tamponade which is 
associated with high mortality. Pathophysiologically, it is 
explained by the progressive accumulation of pericardial 
fluid, which leads to an alteration of ventricular filling, 
directly causing a decrease in cardiac output, and 
hemodynamic repercussions. That is why it was given 
importance and insisted on making use of semiology, since 
the MPE can be suspected with the presence of jugular 
ingurgitation, veiled heart sounds, and hypotension, which is 
known as Beck's triad or with the presence of a paradoxical 
pulse (13, 14).
Our patient initiated with a short clinical evolution with 
rapidly progressive symptoms, leading him to a state of 
Figure 3. CHEST CT.  Osteolytic lesion in right scapula.
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marked functional class deterioration. Initially with stable 
vital signs, but during medical observation he showed 
hemodynamic decompensation of abrupt onset requiring an 
urgent treatment. This is the reason why doctors always 
insist on performing, in the emergency department, an early 
approximated diagnosis and start  a subsequent 
comprehensive management to identify the source of the 
clinical problem; therefore, preventing disease progression 
and further complications is important, such as cardiac 
tamponade, which is an event that involves significantly 
hemodynamic parameters and if there is not an appropriate 
treatment plan, this will quickly lead to the death of the 
individual (15, 16).
The prognosis of patients that present MPE is poor and is 
directly related to the primary source of the malignancy and 
sensitivity to the anticancer treatment. The tumors that 
frequently compromise the heart are those from pulmonary, 
breast, and hematolymphoid origin (table 1). It is important 
to remember that lung cancer has a higher rate of MPE 
recurrence and lower survival when compared to tumors of 
breast origin or hematolymphoid (9). In this case, the patient 
presents with advanced primary malignancy of pulmonary 
origin, although the prognosis of these patients in the short 
term is poor, deserves a comprehensive approach in order to 
prevent complications and improve the quality of life of 
patients.
Regarding to diagnostic tools, there is a wide range of tests 
and when they are used along with the clinical approach, are 
very useful in the emergency department of a health care 
center. In the case of suspected pericardial effusion or 
cardiac tamponade, the imaging tests should be considered 
as the first choice since it has been shown that the 
contribution of these generate a timely diagnosis of a life-
threatening entity (17-20). Chest radiograph usually shows 
an increase in the size of the cardiac silhouette as a sign of 
pericardial effusion; however, it is important to note that 
there is a group of patients, who initially this radiographic 
feature is not evidenced of anything, so that this may be 
because they have little PE at the time of the exam (21-23). 
Some of these patients tend to quickly accumulate fluid in 
this space, generating an unexpected clinical setting of 
cardiac tamponade (24). As an example of this was the 
patient of this case, whose chest radiograph shows an 
increase in the cardiac silhouette associated with 
retrocardiac opacity without the air bronchograms. 
In this case, the medical staff often gives more importance to 
certain findings; for example in this clinical case, the 
emphasis on the retrocardiac is the opacity and did not 
conduct a comprehensive approach with all the imaging and 
initial clinical findings that the patient presented, leading 
him to a decompensation and some complications for him.
Moreover, the transthoracic echocardiogram is considered 
as the frontline for the diagnostic study of pericardial 
effusion, given its cost-effectiveness and high sensitivity 
 and specificity, and a low risk for the patient (10).In patients 
with suspected cardiac tamponade, the most characteristic 
Table 1.  Primary malignant tumors associated with malignant pericardial effusion.
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echocardiographic findings are the presence of pericardial 
effusion associated with collapse of the walls of the right 
atrium and/or right ventricle in diastole (8).  Although, in 
some patients the presence of DP without the collapse of the 
atrial or ventricular walls is evident; so the patients should 
be strictly monitored since much of this rapid progress to a 
hemodynamic instability is due to this monitoring. As this 
example showed if the patient had not done clinical 
monitoring and timely maneuvers decompression, the final 
outcome would have been his death. Also, the patient had a 
low voltage electrocardiogram (EKG), so it must be 
highlighted the importance of a proper performance and 
interpretation of EKG, since there is evidence of the 
association between cardiac tamponade and the low voltage 
in the electrocardiographic tracing, along with a 
considerable diagnostic accuracy (10, 25).
The management and an ideal treatment of MPE still 
remains as a topic of controversy since there are minimally 
invasive techniques that are associated with a higher 
probability of recurrence. Although, there are techniques 
that need to be performed in a surgical area, but with a lower 
recurrence rate of effusion (16). That is why, it is very 
important to individualize management according to the 
clinical evolution and specific requirements of each clinical 
presentation.
Among the different procedures performed to drain a PE, 
pericardiocentesis is the fastest procedure that can be 
performed and carried out in the reanimation room. This 
procedure is indicated in patients with clinical signs and / or 
imaging of cardiac tamponade, or for those who are 
presenting an imminent risk of tamponade or as a diagnostic 
method in cases that pericardial effusion of malignant origin 
is suspected (9). Therefore, it is important to point out that if 
you are in a hospital that has the necessary elements for the 
pericardiocentesis and trained personnel, the procedure 
should be performed on time without any delays when 
making this decision; also, take into account the risk-benefit 
present in these patients in order to avoid complications in 
their health.
Nowadays, there is a triage strategy for the cardiac 
tamponade emergency management of the European 
Society of Cardiology. Members propose a step scoring 
system for the classification of the patient requiring urgent 
percutaneous drainage or surgery if the patient´s process is 
delayed. This classification is divided into three steps with 
their respective punctuations. The first step refers to the 
etiology. The second to the clinical manifestations; the third 
refers to the imaging findings, if the sum gives a greater or 
equal value to 6, so the performance of urgent 
pericardiocentesis is indicated (25). In this clinical case, the 
patient had a rating more than 6, indicating the performance 
of the method already described. 
Other procedures to be performed are the subxiphoid 
pericardiotomy, thoracoscopic pericardiotomy, sternotomy 
pericardiotomy, and thoracotomy pericardiotomy. It is very 
important to evaluate the necessity and appropriateness of 
the procedure with a comprehensive approach to determine 
the risk and benefit for each particular case (26).
Conclusions
The malignant pericardial effusion is an event with 
imminent risk to patients' lives. In some cases, its clinical 
manifestations are of sudden onset. Therefore, it is very 
important to make an early diagnosis and initiate with all 
necessary measures to prevent fatal outcomes as a result of 
the progression of cardiac tamponade; although in some 
individuals, the prognosis is poor.
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